Menu
Log in
Forgot password


Log in
Forgot password

RARE HISTIOCYTOSES STEERING COMMITTEE

The Rare Histiocytoses Steering Committee is responsible for charting strategic direction of the HS in their specified areas, including conduct of clinical trials and engagement with the broader group of investigators interested in rare histiocytoses.

RARE HISTIOCYTOSES STEERING COMMITTEE REPORTS

July 2019 Rare Histiocytoses
Steering Committee Report

RARE HISTIOCYTOSES STEERING COMMITTEE MEMBERS

Eli Diamond - Chair
Memorial Sloan Kettering Cancer Center - New York, NY, USA
Term of Office: 2020 - 2024

Jean-Francoise Emile - Vice-Chair
Versailles University, Paris-Saclay University - Boulogne, France
Term of Office: 2017 - 2021

Oussama Abla 
The Hospital for Sick Children – Toronto, ON, Canada
Term of Office: 2016 - 2020

Jorge Braier
Hospital Garahan – Buenos Aires, Argentina
Term of Office: 2016 - 2020

Benjamin Durham
Memorial Sloan Kettering Cancer Center - New York, NY USA
Term of Office: 2017 - 2021

Michael Girschikofsky
Elisabethinen Hospital – Linz, Austria
Term of Office: 2017 - 2021



Gaurav Goyal
University of Alabama at Birmingham - Birmingham, AL USA
Term of Office: 2020 - 2024

Julien Haroche
Hopital Pitie-Salpetriere - Paris, France
Term of Office: 2018 - 2022

Eric Jacobsen
Dana Farber Cancer Institute - Boston, MA, USA
Term of Office: 2019 - 2023

Zdenka Krenova
University Children Hospital, Brno, ICRC Brno - Brno, Czech Republic
Term of Office: 2019 - 2023

Akira Morimoto
Jichi Medical University - Shimotsuke, Japan
Term of Office: 2017 - 2021

Jennifer Picarsic
Cincinnati Children’s Hospital Medical Center - Cincinnati, OH, USA
Term of Office: 2019 - 2023



Office: +1 (856) 589-6606
Fax: +1 (856) 589-6614
Email: secretariat@histiocytesociety.org

Histiocyte Society
332 N Broadway
Pitman, NJ 08071 USA

Powered by Wild Apricot Membership Software